Helping Black and Latinx patients with rheumatic diseases get recommended COVID-19 vaccines
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases
This project helps Black and Latinx adults living with autoimmune rheumatic diseases get their recommended COVID-19 vaccines.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11061299 on NIH RePORTER |
What this research studies
Many Black and Latinx adults with autoimmune rheumatic diseases have not received all recommended COVID-19 vaccine doses. This project creates a special program that includes personal stories from vaccinated patients and support from a patient navigator. We will test this program in a large group of patients to see if it helps more people get vaccinated. Our goal is to make it easier for patients to understand vaccine recommendations and overcome any challenges to getting their shots.
Who could benefit from this research
Good fit: Ideal candidates are Black or Latinx adults aged 21 or older who have an autoimmune rheumatic disease and may need help with COVID-19 vaccination.
Not a fit: Patients who have already received all recommended COVID-19 vaccine doses or do not have an autoimmune rheumatic disease may not directly benefit from this specific program.
Why it matters
Potential benefit: If successful, this program could significantly increase COVID-19 vaccine rates among Black and Latinx patients with rheumatic diseases, potentially improving their health outcomes.
How similar studies have performed: Community-engaged methods and patient navigation have shown promise in improving health behaviors in other areas, but this specific combination for COVID-19 vaccine uptake in this patient group is being newly tested.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Danila, Maria Ioana — University of Alabama at Birmingham
- Study coordinator: Danila, Maria Ioana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.